VIALE, GIULIA
VIALE, GIULIA
Universita' degli Studi di MILANO
Anti-epidermal growth factor receptor skin toxicity : a matter of topical hydration
2016-01-01 D. Ferrari, C. Codecà, B. Bocci, F. Crepaldi, M. Violati, G. Viale, C. Careri, S. Caldiera, V. Bordin, A. Luciani, S. Zonato, G. Cassinelli, P. Foa
Breast implant-associated anaplastic large cell lymphoma: A comprehensive review
2020-03-01 A. Marra, G. Viale, S. Pileri, G. Pravettoni, G. Viale, F. De Lorenzi, F. Nolè, P. Veronesi, G. Curigliano
Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer
2018-02-19 B. Duso, D. Trapani, G. Viale, C. Criscitiello, P. D'Amico, C. Belli, L. Mazzarella, M. Locatelli, I. Minchella, G. Curigliano
A clinical perspective on escalating or de-escalating adjuvant therapy in HER2+ breast cancer
2019-01-02 A. Esposito, G. Viale, C. Criscitiello, G. Curigliano
Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life
2019-01-01 S. Morganti, P. Tarantino, E. Ferraro, P. D'Amico, G. Viale, D. Trapani, B.A. Duso, G. Curigliano
Crosstalk between bone niche and immune system : osteoimmunology signaling as a potential target for cancer treatment
2015-01-01 C. Criscitiello, G. Viale, L. Gelao, A. Esposito, M. De Laurentiis, S. De Placido, M. Santangelo, A. Goldhirsch, G. Curigliano
Dinaciclib for the treatment of breast cancer
2014-01-01 C. Criscitiello, G. Viale, A. Esposito, G. Curigliano
Extending indication of cyclin-dependent kinase 4/6 inhibitors in the adjuvant and neoadjuvant setting
2017-01-01 C. Carmen, G. Viale, G. Curigliano
Impact of autoimmune diseases on outcome of patients with early breast cancer
2016-01-01 C. Criscitiello, V. Bagnardi, A. Esposito, L. Gelao, B. Santillo, G. Viale, N. Rotmensz, A. Goldhirsch, G. Curigliano
Impact of neoadjuvant chemotherapy and pathological complete response on eligibility for breast-conserving surgery in patients with early breast cancer: A meta-analysis
2018-07-01 C. Criscitiello, M. Golshan, W.T. Barry, G. Viale, S. Wong, M. Santangelo, G. Curigliano
Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy
2014-01-01 C. Criscitiello, L. Gelao, G. Viale, A. Esposito, G. Curigliano
Mismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy Efficacy
2017-01-01 G. Viale, D. Trapani, G. Curigliano
Peptide vaccines in early breast cancer
2019-04-01 C. Criscitiello, G. Viale, G. Curigliano
Targeting the microenvironment in solid tumors
2018-01-01 C. Belli, D. Trapani, G. Viale, P. D'Amico, B. Achutti Duso, P. Della Vigna, F. Orsi, G. Curigliano
Tumor-infiltrating lymphocytes (TILs) in ER+/HER2− breast cancer
2020-09-01 C. Criscitiello, A. Vingiani, P. Maisonneuve, G. Viale, G. Viale, G. Curigliano
An unusual case of tracheo-pleural fistula and cardiac metastases in oropharyngeal carcinoma: a case report and review of the literature
2016-01-01 D. Ferrari, C. Codecà, G. Viale, B. Bocci, F. Broggio, F. Crepaldi, M. Violati, A. Luciani, D. Bauer, L. Moneghini, G. Bulfamante, P. Foa, G. Viale
What therapies are on the horizon for HER2 positive breast cancer?
2019-01-01 G. Viale, S. Morganti, E. Ferraro, P. Zagami, A. Marra, G. Curigliano